82 related articles for article (PubMed ID: 18774710)
1. Design and synthesis of AX4697, a bisindolylmaleimide exo-affinity probe that labels protein kinase C alpha and beta.
Liu Y; Wu J; Weissig H; Betancort JM; Gai WZ; Leventhal PS; Patricelli MP; Samii B; Szardenings AK; Shreder KR; Kozarich JW
Bioorg Med Chem Lett; 2008 Nov; 18(22):5955-8. PubMed ID: 18774710
[TBL] [Abstract][Full Text] [Related]
2. Towards configurationally stable bisindolylmaleimide cyclophanes: potential tools for investigating protein kinase function.
Bartlett S; Nelson A
Chem Commun (Camb); 2004 May; (9):1112-3. PubMed ID: 15116210
[TBL] [Abstract][Full Text] [Related]
3. Indolyl-naphthyl-maleimides as potent and selective inhibitors of protein kinase C-α/β.
van Eis MJ; Evenou J; Schuler W; Zenke G; Vangrevelinghe E; Wagner J; von Matt P
Bioorg Med Chem Lett; 2017 Feb; 27(4):781-786. PubMed ID: 28131714
[TBL] [Abstract][Full Text] [Related]
4. PKCalpha reduces the lipid kinase activity of the p110alpha/p85alpha PI3K through the phosphorylation of the catalytic subunit.
Sipeki S; Bander E; Parker PJ; Faragó A
Biochem Biophys Res Commun; 2006 Jan; 339(1):122-5. PubMed ID: 16297884
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of bisindolylmaleimide and amino acid ester conjugates.
Wang K; Li XY; Chen XG; Liu ZZ
J Asian Nat Prod Res; 2010 Jan; 12(1):36-42. PubMed ID: 20390741
[TBL] [Abstract][Full Text] [Related]
6. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of N-methyl-bisindolylmaleimide derivatives as cell death inhibitors.
Katoh M; Dodo K; Fujita M; Sodeoka M
Bioorg Med Chem Lett; 2005 Jun; 15(12):3109-13. PubMed ID: 15896957
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides.
Davis PD; Hill CH; Lawton G; Nixon JS; Wilkinson SE; Hurst SA; Keech E; Turner SE
J Med Chem; 1992 Jan; 35(1):177-84. PubMed ID: 1732526
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of N-methyl-bisindolylmaleimide amino acid methyl ester conjugates and cytotoxicity study.
Wang K; Liu ZZ
Eur J Med Chem; 2010 Sep; 45(9):4175-9. PubMed ID: 20598779
[TBL] [Abstract][Full Text] [Related]
11. Structure of the catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor.
Grodsky N; Li Y; Bouzida D; Love R; Jensen J; Nodes B; Nonomiya J; Grant S
Biochemistry; 2006 Nov; 45(47):13970-81. PubMed ID: 17115692
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors.
Tanaka M; Sagawa S; Hoshi J; Shimoma F; Matsuda I; Sakoda K; Sasase T; Shindo M; Inaba T
Bioorg Med Chem Lett; 2004 Oct; 14(20):5171-4. PubMed ID: 15380221
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of 7-azaindazolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors.
Ye Q; Shen Y; Zhou Y; Lv D; Gao J; Li J; Hu Y
Eur J Med Chem; 2013 Oct; 68():361-71. PubMed ID: 23994329
[TBL] [Abstract][Full Text] [Related]
14. Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safety.
Zhang HC; Derian CK; McComsey DF; White KB; Ye H; Hecker LR; Li J; Addo MF; Croll D; Eckardt AJ; Smith CE; Li Q; Cheung WM; Conway BR; Emanuel S; Demarest KT; Andrade-Gordon P; Damiano BP; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1725-8. PubMed ID: 15771419
[TBL] [Abstract][Full Text] [Related]
15. Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors.
Brehmer D; Godl K; Zech B; Wissing J; Daub H
Mol Cell Proteomics; 2004 May; 3(5):490-500. PubMed ID: 14769951
[TBL] [Abstract][Full Text] [Related]
16. Chemical modification of the naphthoyl 3-position of JWH-015: in search of a fluorescent probe to the cannabinoid CB2 receptor.
Yates AS; Doughty SW; Kendall DA; Kellam B
Bioorg Med Chem Lett; 2005 Aug; 15(16):3758-62. PubMed ID: 15993070
[TBL] [Abstract][Full Text] [Related]
17. Protein Kinase C- alpha/betaII, delta, and zeta/lambda involvement in ethanol-induced MAPK expression in vascular smooth muscle cells.
Johnson AL; Goode GD; Mtshali C; Myles EL; Washington B
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):38-44. PubMed ID: 17531159
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors.
Peifer C; Stoiber T; Unger E; Totzke F; Schächtele C; Marmé D; Brenk R; Klebe G; Schollmeyer D; Dannhardt G
J Med Chem; 2006 Feb; 49(4):1271-81. PubMed ID: 16480264
[TBL] [Abstract][Full Text] [Related]
19. Effects of bisindolylmaleimide PKC inhibitors on p90RSK activity in vitro and in adult ventricular myocytes.
Roberts NA; Haworth RS; Avkiran M
Br J Pharmacol; 2005 Jun; 145(4):477-89. PubMed ID: 15821757
[TBL] [Abstract][Full Text] [Related]
20. Evidence on the participation of protein kinase C alpha in the proliferation of cultured myoblasts.
Capiati DA; Limbozzi F; Téllez-Iñón MT; Boland RL
J Cell Biochem; 1999 Aug; 74(2):292-300. PubMed ID: 10404397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
